Research Article
Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients
Table 1
Frequency of hormone receptors and breast cancer types.
| Breast cancer types | Receptors types | Percent |
| IDC | ER/PR+ | 33% | ER/PR− | 56% | DCIS, mucinous carcinoma | HER-2+ | 82.4% | HER-2− | 84.6% | IDC, medullary carcinoma | P53+ | 90% | P53− | 85.7% | medullary carcinoma, ILC, and IDC | PR+ | 85.7% | PR− | 56% |
|
|